Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes

• Status: Not yet recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this project is to investigate the effects of riboflavin, also known as vitamin B2, on preventing delayed onset muscle soreness (DOMS) in ultramarathon athletes through a randomized placebo-controlled study.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The University of Texas Health Science Center at San Antonio
• Collaborator: Racing the Planet
• Treatments: Riboflavin

Criteria

Inclusion Criteria:

1. Provision of signed and dated informed consent form

2. Stated willingness to comply with all study procedures and availability for the duration of the study

3. Male or female, aged 18 or over

4. In good general health as evidenced by readiness to participate in an ultramarathon

5. Ability to take oral medication and be willing to adhere to the study regimen

6. For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening.

Exclusion Criteria:

1. Unable to read or understand English

2. Under 18 years of age

3. Pregnancy or lactation

4. Known allergic reactions to components of the investigational drugs